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TO THE EDITOR
Atopic eczema (AE) (OMIM %603165)
is the most common chronic inflamma-
tory skin disease, characterized by xero-
sis, pruritus, and erythematous lesions
with increased transepidermal water
loss. In recent years, it has been sug-
gested that the epidermal skin barrier has
a significant role in AE disease suscept-
ibility and severity (Smith et al., 2006;
Cork et al., 2009). Sandilands et al.
(2006) demonstrated that null mutations
within the filaggrin gene (FLG) strongly
predispose individuals to AE. Two FLG
null alleles (R501X and 2282del4) have
been shown to be significantly asso-
ciated with AE in several European
populations (Palmer et al., 2006;
Weidinger et al., 2007). Recently, a
meta-analysis of the most common FLG
variants in European populations, invol-
ving 5,791 eczema cases and 26,454
controls (Rodriguez et al., 2009), re-
vealed that there is a high risk conferred
by R501X and 2282del4 across the
studies, with an overall odds ratio of
3.14 and 2.78, respectively. Indeed,
large differences in carrier frequencies
exist across Europe, ranging from 1.4%
in an Italian population (Giardina et al.,
2008) to 63% in an Irish population
(Palmer et al., 2006). Recently, we
observed that in Italian patients the
frequencies of R501X and 2282del4 are
strongly reduced with respect to those
described in other patients of European
origin, and the frequencies are similar
between cases and controls (0.6 vs.
0.0% and 0.9 vs. 0.5%, respectively).
In order to determine whether other
mutations located elsewhere in FLG
confer risk to AE, we performed a full
sequencing of FLG in Italian patients.
We performed a sequencing of the
full FLG gene in a cohort of 220 Italian
AE patients (recruited by IDI-Istituto
Dermopatico dell’Immacolata and
Fatebenefratelli Hospital). We then
determined the frequency of variations
and mutations in a cohort of 201
healthy subjects. The diagnosis of AE
in our case cohort was made by
experienced dermatologists or by a
pediatric allergologist. The cohort con-
sisted of 85% of cases with the intrinsic
subtype and 15% with the extrinsic
form of AE. These subtypes and severity
of AE have been established based on
the total IgE level (extrinsic subtype
4500 ng l1) and using the scoring
atopic dermatitis. Further clinical de-
tails of Italian patients are available inAbbreviations: AE, atopic eczema; FLG, filaggrin gene; LD, linkage disequilibrium
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Bergboer et al. (2010). Written consent
was obtained from all of the patients or
their parents. The study was approved
by the ethics committee of each parti-
cipating institute and complied with the
guidelines of the Declaration of Helsinki.
Genomic DNA was extracted from
peripheral blood using standard proce-
dures. Sequence analysis of the third
exon of FLG using 11 overlapping
fragments amplified by 11 sequence-
specific primer pairs was performed
(see Supplementary Table S1 online).
Furthermore, the promoter region and
exon 2 were also analyzed. PCR frag-
ments were run on an ABI 3130xl
automated sequencer (Applied Bio-
systems, Foster City, CA). We identified
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Figure 1. FLG null mutations and linkage disequilibrium (LD) plot. (a) Electropherograms of the null mutations. (b) Gene location of filaggrin (FLG) null
mutations. (c) LD pattern in atopic eczema cases. (d) LD pattern in healthy controls.
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three null mutations that, to our
knowledge, are previously unreported
(R1798X (5392 C4T), E3603X (10810
G4T), and R3638X (10912 A4T))
(Figure 1a and b) and are located in
the repeats 5 (R1798X) and 10 (E3603X
and R3638X), adjacent to the other
null mutations identified thus far. Sub-
sequently, we assessed the frequency of
the mutations in 201 healthy controls.
We found that the frequency of the
mutations was similar in the cases
and controls (Table 1). The mutations
R1798X and E3603X are rare in an
Italian population, and, although not
statistically significant, further studies in
Italians, as well as other populations,
will be needed to confirm their fre-
quency and/or rule out a functional
role. The null mutation, R3638X, has
a higher frequency in healthy controls
(4%) and might be considered a poly-
morphic variant. Moreover, we identi-
fied a number of variations, but failed
to observe evidence of an association
in our patients. Therefore, it is likely
that in Italian cases there are other
genes associated with the 1q21 region
(ATOD2). In this regard, we believe
that a study involving Italians, as well
as other 1q21-linked samples, can be
particularly useful to detect population-
specific associated alleles. As in a
critical region that harbors the suscept-
ibility variant the extent of linkage
disequilibrium (LD) may be different
between cases and controls, we
decided to contrast LD patterns be-
tween AE cases and controls (Figure 1c
and d). We considered all the variations
with a frequency 40.1 at the FLG locus
and found a different pattern of LD.
In particular, we observed a more
conserved block between markers
rs12405241 and 1432 in controls
with respect to the cases. Although
these data need to be replicated in
other populations and using a higher
number of markers, it is suggested that
disease-bearing chromosomes and con-
trol chromosomes arise from different
pools, with disease-bearing chromo-
somes showing greater heterogeneity.
Further studies will be needed to verify
the existence of multiple susceptibility
alleles spanning the ATOD2 locus.
Taken together, these results demon-
strate that only a small percentage of
Italian AE patients carry mutations in
the FLG gene, which therefore should
not be considered as a major risk factor
for AE in the Italian population. The low
frequency of FLG null alleles and the
absence of association in the AE cohort
may reflect the strong purifying selec-
tion of FLG mutations in chromosome 1
of Italian patients. In this regard, it is
notable that the frequency of mutations
is strongly reduced in healthy controls
with respect to that observed in differ-
ent European populations, further sup-
porting the existence of a different
ethnic origin of Italian population and
ruling out a possible confounding effect
of clinical and genetic heterogeneity
characterization of samples. An alter-
native explanation would be that the
mutations are strongly advantageous in
northern Europe. As a result, the geo-
graphic distribution of the frequencies
of FLG mutations is heterogeneous among
European populations. Currently there
is no evidence of FLG mutations in
Mediterranean populations, making
possible the existence of a population-
specific gradient across Europe. With
this perspective in mind, a pan-Eur-
opean study of FLG mutations should
be conducted to further address this
hypothesis.
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Table 1. Allele frequencies of three unreported mutations
R1798X_C4T E3603X_G4T R3638X_A4T
Allele C T G T A T
Cases 0.998 0.002 0.995 0.005 0.97 0.03
Controls 0.997 0.003 1 0 0.96 0.04
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